Spots Global Cancer Trial Database for extramedullary plasmacytoma
Every month we try and update this database with for extramedullary plasmacytoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma | NCT02336386 | Extramedullary ... | CDD CDD Plus Bortez... | 18 Years - | Beijing Chao Yang Hospital | |
| Beta Alethine in Treating Patients With Myeloma | NCT00006466 | Multiple Myelom... Precancerous Co... | beta alethine | 18 Years - | National Cancer Institute (NCI) | |
| PS-341 in Treating Patients With Advanced Cancer | NCT00006362 | Leukemia Lymphoma Multiple Myelom... Precancerous Co... Unspecified Adu... | bortezomib | 18 Years - | Mayo Clinic | |
| Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma | NCT01849783 | Extramedullary ... Isolated Plasma... Light Chain Dep... Primary Systemi... Stage I Multipl... Stage II Multip... Stage III Multi... | dexamethasone cisplatin doxorubicin cyclophosphamid... etoposide bortezomib thalidomide melphalan autologous stem... | 65 Years - 85 Years | University of Iowa | |
| CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma | NCT02336386 | Extramedullary ... | CDD CDD Plus Bortez... | 18 Years - | Beijing Chao Yang Hospital | |
| Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma | NCT01849783 | Extramedullary ... Isolated Plasma... Light Chain Dep... Primary Systemi... Stage I Multipl... Stage II Multip... Stage III Multi... | dexamethasone cisplatin doxorubicin cyclophosphamid... etoposide bortezomib thalidomide melphalan autologous stem... | 65 Years - 85 Years | University of Iowa | |
| Beta Alethine in Treating Patients With Myeloma | NCT00006466 | Multiple Myelom... Precancerous Co... | beta alethine | 18 Years - | National Cancer Institute (NCI) | |
| Short Course Daratumumab in Patients With Multiple Myeloma | NCT03490344 | Multiple Myelom... | Daratumumab Lenalidomide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma | NCT00109889 | Multiple Myelom... Plasmacytoma | magnetic resona... positron emissi... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients | NCT04008888 | Multiple Myelom... Plasma Cell Leu... Extramedullary ... Loss of Chromos... t(14;16) t(4;14) T(14;20) 1Q21 Amplificat... Complex Karyoty... | Allogeneic Hema... Autologous Hema... Melphalan Given... Fludarabine Inj... PI and dexameth... PI+IMids+Dexame... | 18 Years - 60 Years | Institute of Hematology & Blood Diseases Hospital, China | |
| S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma | NCT00109889 | Multiple Myelom... Plasmacytoma | magnetic resona... positron emissi... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant | NCT00002657 | Lymphoma Multiple Myelom... | bleomycin sulfa... recombinant int... cyclophosphamid... cytarabine doxorubicin hyd... etoposide methotrexate prednisone vincristine sul... conventional su... radiation thera... | 15 Years - | SWOG Cancer Research Network | |
| Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease | NCT04166565 | Multiple Myelom... Extramedullary ... | Daratumumab Bortezomib Cyclophosphamid... Dexamethasone | 18 Years - | Stichting European Myeloma Network | |
| Short Course Daratumumab in Patients With Multiple Myeloma | NCT03490344 | Multiple Myelom... | Daratumumab Lenalidomide | 18 Years - | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
